Medications Semaglutide, known by the brand name Wegovy, and liraglutide (Saxenda) have been specifically approved for weight loss in obesity, in combination with lifestyle changes
This treatment utilizes GLP-1, a hormone naturally produced in the body, to help regulate these essential functions
During the early stages, nausea is one of the most common symptoms, which often improves as you approach your target dose
it does not trigger refunds for charges already processed
Compounded medications contain the same active pharmaceutical ingredient as the FDA-approved brand-name drugs (Wegovy, Ozempic, Zepbound, Mounjaro), but the compounded versions themselves are not FDA-approved as finished products and have not been individually evaluated by the FDA for safety, efficacy, or quality
GLP-1 receptor agonists do not affect sodium intake: Exploratory analyses from two randomized clinical trials